New Leaf Venture Partners as of Dec. 31, 2016
Portfolio Holdings for New Leaf Venture Partners
New Leaf Venture Partners holds 15 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Versartis | 21.8 | $30M | 2.0M | 14.90 | |
| Edge Therapeutics | 21.0 | $29M | 2.3M | 12.50 | |
| Oxford Immunotec Global | 14.8 | $21M | 1.4M | 14.95 | |
| Wave Life Sciences (WVE) | 12.3 | $17M | 658k | 26.15 | |
| Crispr Therapeutics (CRSP) | 8.5 | $12M | 587k | 20.26 | |
| Dimension Therapeutics | 6.4 | $9.0M | 2.1M | 4.35 | |
| Sage Therapeutics (SAGE) | 4.2 | $5.8M | 114k | 51.06 | |
| Dermira | 3.9 | $5.4M | 178k | 30.33 | |
| Alder Biopharmaceuticals | 3.4 | $4.8M | 228k | 20.80 | |
| AVEO Pharmaceuticals | 1.0 | $1.4M | 2.6M | 0.54 | |
| Vistagen Therapeutics | 0.9 | $1.3M | 353k | 3.73 | |
| Dynavax Technologies (DVAX) | 0.7 | $1.0M | 256k | 3.95 | |
| Lombard Med (EVARF) | 0.5 | $644k | 1.1M | 0.60 | |
| Trillium Therapeutics, Inc. Cmn | 0.4 | $547k | 97k | 5.65 | |
| Inotek Pharmaceuticals | 0.3 | $380k | 62k | 6.10 |
